Medicare Advantage and Prescription Drug Benefit Program Changes

CMS proposed rule on Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. The Rule will reduce out-of-pocket prescription drug costs, improve price transparency, strengthen consumer protections, and more.

Related Keywords

United States , , Health Outcomes Survey , Communications Requirements , Medicaid Agency , Determinants Of Health , Transportation Questions On Health Risk Assessments , Centers For Medicare , Clinical Laboratory Improvement Amendments , Amend Ma Network Adequacy , Party Marketing Organizations And Addressing Other , Medicaid Services , A Compliant Network At Application , Public Health Emergency , Contract Year , Technical Changes , Medicare Advantage , Medicare Prescription Drug Benefit Programs , Proposed Rule , Plan Governance , Medicare Medicaid Plans , Inclusive Care , Food Insecurity , Transportation Questions , Health Risk Assessments , Social Determinants , United States Core Data , Interoperability Version , Fully Integrated , Highly Integrated , State Medicaid , State Medicaid Agency , Star Ratings , Maximum Out Of Pocket Limit , Medicare Part , Medicare Parts , Federal Medicaid , Adequacy Rules , Compliant Network , Calculate Star Ratings , Certain Measures , Health Emergency , Medicaid Programs , Regulatory Revisions , Patient Protection , Affordable Care Act , Additional Policy , Healthcare Effectiveness Data , Information Set , Monitoring Physical Activity , Improving Bladder Control , Individual Assistance , Performance Methodology , Better Hold Plans Accountable , Ratings History , Warning Letters , Corrective Action Plans , Plan Oversight , Medical Loss Ratio Reporting , President Trump , Executive Order , Price Concessions , Drug Prices , Legal , Dministrative , Healthcare , Ms , Ms Medicare Advantage Program , Out Of Pocket Prescription Drug Costs , Prescription Costs , Drug Price Transparency ,